CORT FY 2017 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$159M+95.8% YoY

Gross Profit

$156M97.8% margin

Operating Income

$53M33.2% margin

Net Income

$129M81.1% margin

EPS (Diluted)

$1.04

Cash Flow

Operating Cash Flow

$61M

Free Cash Flow

$61M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$221M

Total Liabilities

$30M

Stockholders' Equity

$191M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$159M	$81M	+95.8%
Gross Profit	$156M	$79M	+96.4%
Operating Income	$53M	$10M	+419.3%
Net Income	$129M	$8M	+1486.3%